RESMED, INC.

(RMD)
  Report
Delayed Nyse  -  04:00 2022-08-16 pm EDT
236.10 USD   -0.43%
10:04aWhat do investors want?
MS
05:42aANALYST RECOMMENDATIONS : Visa, Mastercard, ResMed, Extra Space Storage, Equifax...
MS
08/15Morgan Stanley rates RMD as Equal-weight
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on RESMED, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) RESMED, INC.
Analyst Recommendations on RESMED, INC.
05:42aANALYST RECOMMENDATIONS : Visa, Mastercard, ResMed, Extra Space Storage, Equifax...
MS
08/12Morgan Stanley Adjusts Price Target for ResMed to $222 From $204, Maintains Equalweight Ra..
MT
08/12JPMorgan Downgrades ResMed to Neutral From Overweight, Lowers Price Target to $250 From $2..
MT
08/12RBC Downgrades ResMed to Sector Perform From Outperform, Citing Valuation, But Lifts Price..
MT
08/12Citigroup Downgrades ResMed to Neutral From Buy
MT
06/15RBC Lifts Price Target on ResMed to $247 From $244 Amid MEDIFOX DAN Deal, Maintains Outper..
MT
06/06RBC Upgrades ResMed to Outperform From Sector Perform, Citing 'Attractive Entry Point,' Ra..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 236,10 $
Average target price 252,50 $
Spread / Average Target 6,95%
High Price Target 276,00 $
Spread / Highest target 16,9%
Low Price Target 222,00 $
Spread / Lowest Target -5,97%
Consensus detail
Consensus revision (last 18 months)